Related Experiment Videos
Multimodality therapy for esophageal cancer.
1The Cancer Institute, St. Joseph Medical Center, Towson, Maryland 21204, USA. markkrasna@catholichealth.net
Oncology (Williston Park, N.Y.)
|December 15, 2010
Summary
Management of esophageal and gastroesophageal junction cancers has evolved. While antireflux surgery doesn't prevent esophageal adenocarcinoma, updated staging and neoadjuvant chemoradiation improve outcomes for advanced stages.
Area of Science:
- Gastroenterology and Oncology
- Surgical Oncology
Background:
- Esophageal and gastroesophageal junction cancers require updated management strategies.
- Gastroesophageal reflux disease is linked to esophageal cancer, but antireflux surgery offers no preventive benefit for adenocarcinoma.
Purpose of the Study:
- To review recent advancements in the epidemiology, staging, and treatment of esophageal and gastroesophageal junction cancers.
- To highlight changes in clinical management based on new evidence.
Main Methods:
- Literature review of recent developments in esophageal cancer research.
- Analysis of updated staging systems and treatment modalities.
- Evaluation of the impact of surgical volume and advanced diagnostic techniques.
Main Results:
- Antireflux surgery does not prevent esophageal adenocarcinoma.
- A modified staging system aids in determining optimal lymph node dissection during esophagectomy.
- Advanced imaging (esophageal ultrasound, PET) and fine needle aspiration enhance staging accuracy.
- High-volume centers and surgeons correlate with improved outcomes for upper gastrointestinal cancers.
- Neoadjuvant chemoradiation is the emerging standard for Stage II and III esophageal cancer.
Conclusions:
- Current management of esophageal and gastroesophageal junction cancers emphasizes refined staging and neoadjuvant therapy.
- Optimizing surgical approach and utilizing advanced diagnostics are crucial for better patient outcomes.
Related Concept Videos
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...